Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Severe Acute Pancreatitis
NCT02318134Phase 2Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Nov 2017
- Primary completion
- Apr 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in acute pancreatitis (AP), sponsored by First Affiliated Hospital of Nanchang University. Started Nov 2017; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02318134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318134.